EIF4A1 and ganglioneuroblastoma: This finding is independent of whether the tissue originated from patients with ganglioneuroblastoma or NB, tumor localization, or MYCN amplification status, Additionally, EIF4A1 overexpression did not affect the patient’s OS (dataset from TARGET initiative).